Charles Schwab Investment Management »

Relmada Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $52k 13k 4.14
2023-09-30 $38k 13k 3.00
2023-06-30 $31k 13k 2.46
2023-03-31 $167k 74k 2.26
2022-12-31 $214k 61k 3.49
2022-09-30 $2.6M 71k 37.03
2022-06-30 $1.4M 73k 18.99
2022-03-31 $1.8M 67k 27.00
2021-12-31 $1.0M 45k 22.55
2021-09-30 $1.1M 41k 26.23
2021-06-30 $3.2M 99k 32.02
2021-03-31 $3.3M 95k 35.22
2020-12-31 $3.0M 93k 32.07
2020-09-30 $3.4M 89k 37.62
2020-06-30 $4.0M 90k 44.76
2020-03-31 $1.8M 53k 34.13
2019-12-31 $1.9M 49k 39.01